The Current Status and Work of Three Rs Centres and Platforms in Europe*
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Alternatives to Laboratory Animals |
Vol/bind | 50 |
Udgave nummer | 6 |
Sider (fra-til) | 381-413 |
Antal sider | 33 |
ISSN | 0261-1929 |
DOI | |
Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by: the project CERST (Center for Alternatives to Animal Testing) of the Ministry for Culture and Science of the State of North-Rhine Westphalia, Germany (file number 233-1.08.03.03-121972/131–1.08.03.03–121972) to Ellen Fritsche; the ERDF/ESF project ‘International competitiveness of NIPH in research, development and education in alternative toxicological methods’ (No. CZ.02.1.01/0.0/0.0/16_019/0000860) to Dagmar Jírová and Kristina Kejlová; and the MWK-funded 3R Center Rhine-Neckar (FKZ: 33-7533.-6-1522/9/43) to Marcus W. Meinhardt, Rainer Spanagel, Sabine Chourbaji and Bettina Kränzlin. The IC-3Rs at the Vrije Universiteit Brussel (VUB) is supported by the Chair Mireille Aerens for the development of alternative methods and by the Dept. ‘Leefmilieu’ of the Brussels Region under Minister Bernard Clerfayt (SUB/2021/VUB/Bruxelles IC-3Rs) and the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 952404 (TWINALT). This project was partially supported by the Einstein foundation Berlin (EC3R EZ-2020-597-2) to Christa Thöne-Reineke, Jens Kurreck and Stefan Hippenstiel and by Charité 3R to Stefan Hippenstiel, Annemarie Lang, and Ida Retter. In addition, this project was supported by CEFIC, the DK-EPA (MST-667-00205), the Land-BW (NAM-ACCEPT) and funding by the European Union’s Horizon 2020 research and innovation programme under grant agreements No 964537 (RISK-HUNT3R), No. 964518 (ToxFree) and No. 825759 (ENDpoiNTs), and Horizon Europe under grant agreement No. 101057014 (PARC) to Marcel Leist and Giorgia Pallocca from the Center for Alternatives to Animal Testing (CAAT) Europe, and the European Union’s Horizon 2020 research. Moreover, the article is based upon work from COST Action 3Rs concepts to improve the quality of biomedical science (IMPROVE), CA21139 supported by COST (European Cooperation in Science and Technology), www.cost.eu .
Publisher Copyright:
© The Author(s) 2022.
ID: 337594093